Healthcare M&A: The Rise of the Private Equity-backed MSO and DSO

Why have MSOs and DSOs become so attractive to private equity investors in recent years? What are the potential challenges to successfully executing this high-volume roll-up strategy?

In this episode of The Drawdown, we explore these questions and more with Cherry Bekaert Partners Steve Stang and Michael Ludwig as they provide key insights and approaches that can give private equity investors an edge in this competitive marketplace.

Introducing Cherry Bekaert’s Healthcare Micro-Deals Experience: a highly efficient, technology-driven solution for private equity that streamlines MSO or DSO roll-up acquisitions from pre-LOI to post-close integration.

When bringing a new MSO or DSO online, private equity needs a replicable market strategy that is easily scaled for growth.  Efficiency during the diligence stage is essential to achieving high-volume growth objectives while minimizing transaction risks and maximizing long-term returns on investment.


View All The Drawdown Podcasts

 

Michael Ludwig

Deal Advisory Services

Partner, Cherry Bekaert Advisory LLC

Cameron Smith

Transaction Advisory Services

Managing Director, Cherry Bekaert Advisory LLC

Past Episodes

Podcast

September 17, 2024

11:45

Speakers: Christopher J. Truitt, Martin Karamon, William W. Billips, Timothy Doran

Learn how transferable energy tax credits under the Inflation Reduction Act offer private equity funds new tax planning opportunities and innovative deal structuring.

Podcast

September 6, 2024

15:09

Speakers: Lori Smith, Jacqueline (J.C.) Tuthill, John Collier

Understand how business interruption insurance offers private equity firms protection against natural disasters, supply chain disruptions, and cyberattacks.